000915.SZ
Shandong Wit Dyne Health Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 23.80
+0.42%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.0B | 2.2B | 2.1B | 2.5B | 2.3B |
| Cost of Revenue | 322.2M | 331.8M | 345.1M | 337.6M | 501.7M |
| Gross Profit | 1.7B | 1.9B | 1.8B | 2.1B | 1.8B |
| Operating Expenses | |||||
| R&D Expense | 95.5M | 91.1M | 101.4M | 95.6M | 65.6M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 85.5M | 87.0M | 87.2M | 117.8M | 112.2M |
| Selling & Marketing Expense | 463.3M | 492.5M | 417.1M | 631.6M | 488.6M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 662.7M | 688.8M | 615.3M | 859.1M | 688.9M |
| Cost and Expenses | 984.9M | 1.0B | 960.4M | 1.2B | 1.2B |
| Operating Income (EBIT) | 1.0B | 1.2B | 1.2B | 1.3B | 1.2B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 1.0B | 1.2B | 1.2B | 1.3B | 1.2B |
| Income Tax Expense | 153.4M | 178.4M | 172.2M | 198.3M | 161.3M |
| Bottom Line | |||||
| Net Income | 463.3M | 535.1M | 515.6M | 585.3M | 526.9M |
| Earnings from Cont. Ops | 892.1M | 1.0B | 1.0B | 1.1B | 997.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 463.3M | 535.1M | 515.6M | 585.3M | 526.9M |
| Per Share | |||||
| Basic EPS | CN¥1.97 | CN¥2.28 | CN¥2.20 | CN¥2.50 | CN¥2.25 |
| Diluted EPS | CN¥1.97 | CN¥2.28 | CN¥2.20 | CN¥2.50 | CN¥2.25 |
| Revenue Per Share | CN¥8.60 | CN¥9.50 | CN¥9.11 | CN¥10.61 | CN¥10.00 |
| Shares | |||||
| Basic Shares Outstanding | 235.3M | 234.7M | 234.4M | 234.1M | 234.2M |
| Diluted Shares Outstanding | 235.3M | 234.7M | 234.4M | 234.1M | 234.2M |
| Profitability Metrics | |||||
| EBITDA | — | 1.3B | 1.3B | 1.4B | 1.2B |
| D&A | — | 74.9M | 77.2M | 77.2M | 72.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026